Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer
Sheela Rao(Royal Marsden NHS Foundation Trust), A Hill(Royal Marsden NHS Foundation Trust)
Cited by 58
Related Papers
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
|New England Journal of Medicine|2008|2.3k